The promise and challenges of chimeric antigen receptor T cells in relapsed B-cell acute lymphoblastic leukemia

被引：3
|
作者：
Ding, Zhi-Chun [1 ]
机构：
[1] Augusta Univ, Georgia Canc Ctr, Canc Immunol Immunotherapy & Tolerance Program, 1120 15th St,CN4144B, Augusta, GA 30912 USA
来源：
ANNALS OF TRANSLATIONAL MEDICINE | 2018年 / 6卷 / 11期
关键词：
CANCER REGRESSION; METASTATIC MELANOMA; IMMUNOTHERAPY; LYMPHOCYTES; THERAPY; GENE; CYCLOPHOSPHAMIDE; PERSISTENCE; EXPRESSION; RESPONSES;
D O I：
10.21037/atm.2018.05.35
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页数：3
相关论文
共 50 条
  • [21] Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia
    Badar, Talha
    Shah, Nirav N.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2020, 21 (02)
  • [22] Chimeric Antigen Receptor T Cell Therapy for Acute Lymphoblastic Leukemia
    Talha Badar
    Nirav N. Shah
    Current Treatment Options in Oncology, 2020, 21
  • [23] CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS TARGETING THE CD19 ANTIGEN FOR THE TREATMENT OF RELAPSED B CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL)
    Curran, Kevin
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S6 - S6
  • [24] Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells
    Park, Jae H.
    Romero, F. Andres
    Taur, Ying
    Sadelain, Michel
    Brentjens, Renier J.
    Hohl, Tobias M.
    Seo, Susan K.
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (04) : 533 - 540
  • [25] CASES OF RELAPSED AND REFRACTORY B CELL PRECURSOR-ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY
    Kurita, Daisuke
    Yamanishi, Jun
    Osuna, Mitsumasa
    Ikeda, Junji
    Tsujimoto, Shinichi
    Takeuchi, Masanobu
    Tanoshima, Reo
    Shiba, Norio
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S104 - S104
  • [26] Checkpoint Inhibitors Augment CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy in Relapsed B-Cell Acute Lymphoblastic Leukemia
    Li, Amanda M.
    Hucks, George E.
    Dinofia, Amanda M.
    Seif, Alix E.
    Teachey, David T.
    Baniewicz, Diane
    Callahan, Colleen
    Fasano, Christina
    McBride, Beth
    Gonzalez, Vanessa
    Nazimuddin, Farzana
    Porter, David L.
    Lacey, Simon F.
    June, Carl H.
    Grupp, Stephan A.
    Maude, Shannon L.
    BLOOD, 2018, 132
  • [27] Treatment of Testicular Relapse of B-cell Acute Lymphoblastic Leukemia With CD19-specific Chimeric Antigen Receptor T Cells
    Chen, Xiaojuan
    Wang, Ying
    Ruan, Min
    Li, Jun
    Zhong, Mengjun
    Li, Zhanqi
    Liu, Fang
    Wang, Shuchun
    Chen, Yumei
    Liu, Lipeng
    Yang, Jun J.
    Zhu, Xiaofan
    Wang, Jianxiang
    Pui, Ching-Hon
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (06): : 366 - 370
  • [28] Improving and Maintaining Responses in Pediatric B-Cell Acute Lymphoblastic Leukemia Chimeric Antigen Receptor-T Cell Therapy
    Arya, Rahul
    Barrett, David M.
    Grupp, Stephan A.
    Melenhorst, Jan Joseph
    CANCER JOURNAL, 2021, 27 (02): : 151 - 158
  • [29] Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors
    Aldoss, I.
    Bargou, R. C.
    Nagorsen, D.
    Friberg, G. R.
    Baeuerle, P. A.
    Forman, S. J.
    LEUKEMIA, 2017, 31 (04) : 777 - 787
  • [30] Redirecting T cells to eradicate B-cell acute lymphoblastic leukemia: bispecific T-cell engagers and chimeric antigen receptors
    I Aldoss
    R C Bargou
    D Nagorsen
    G R Friberg
    P A Baeuerle
    S J Forman
    Leukemia, 2017, 31 : 777 - 787
12345